205
Views
9
CrossRef citations to date
0
Altmetric
Key Paper Evaluations

Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker?

, , , , &
Pages 793-796 | Published online: 09 Jan 2014

References

  • Cen P, Ni X, Yang J, Graham DY, Li M. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim. Biophys. Acta (BBA) – Rev. Cancer 1826(2), 350–356 (2012).
  • Valastyan S, Weinberg Robert A. Tumor metastasis: molecular insights and evolving paradigms. Cell 147(2), 275–292 (2011).
  • de Albuquerque A, Kubisch I, Breier G et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology 82(1), 3–10 (2012).
  • Ren C, Han C, Zhang J et al. Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy. Cancer Biol. Ther. 12(8), 700–706 (2011).
  • Bidard FC, Huguet F, Louvet C et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann. Oncol. 24(8), 2057–2061 (2013).
  • Tjensvoll K, Nordgard O, Smaaland R. Circulating tumor cells in pancreatic cancer patients: Methods of detection and clinical implications. Int. J. Cancer (2013) (Epub ahead of print).
  • Jacob J, Krell J, Castellano L, Jiao LR, Stebbing J, Frampton AE. Determination of cut-offs for circulating tumor cell measurement in metastatic cancer. Expert Rev. Anticancer Ther. 11(9), 1345–1350 (2011).
  • Rahbari NN, Aigner M, Thorlund K et al. Meta-analysis shows that detection of circulating tumor cells indicates poor prognosis in patients with colorectal cancer. Gastroenterology 138(5), 1714–1726 (2010).
  • de Bono JS, Scher HI, Montgomery RB et al. Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer. Clin. Cancer Res. 14(19), 6302–6309 (2008).
  • Hou JM, Greystoke A, Lancashire L et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am. J. Pathol. 175(2), 808–816 (2009).
  • Galizia G, Gemei M, Orditura M et al. Postoperative detection of circulating tumor cells predicts tumor recurrence in colorectal cancer patients. J. Gastrointest Surg. doi: 10.1007/s11605-013-2258-6 (2013) (Epub ahead of print).
  • Bidard F-C, Mathiot C, Delaloge S et al. Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer. Ann. Oncol. 21(4), 729–733 (2010).
  • Buglione M, Grisanti S, Almici C et al. Circulating tumour cells in locally advanced head and neck cancer: preliminary report about their possible role in predicting response to non-surgical treatment and survival. Euro. J. Cancer 48(16), 3019–3026 (2012).
  • Gall TM, Jacob J, Frampton AE et al. No-touch isolation surgical technique reduces dissemination of circulating tumor cells in patients with pancreatic cancer. Pancreatology 13(3), S28 (2013).
  • Jiao LR, Apostolopoulos C, Jacob J et al. Unique localization of circulating tumor cells in patients with hepatic metastases. J. Clin. Oncol. 27(36), 6160–6165 (2009).
  • Deneve E, Riethdorf S, Ramos J et al. Capture of viable circulating tumor cells in the liver of colorectal cancer patients. Clin. Chem. (2013).
  • Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 139(5), 871–890 (2009).
  • Muller V, Alix-Panabieres C, Pantel K. Insights into minimal residual disease in cancer patients: implications for anti-cancer therapies. Eur. J. Cancer 46(7), 1189–1197 (2010).
  • Rossi E, Basso U, Celadin R et al. M30 neoepitope expression in epithelial cancer: quantification of apoptosis in circulating tumor cells by CellSearch analysis. Clin. Cancer Res. 16(21), 5233–5243 (2010).
  • Paterlini-Brechot P, Benali NL. Circulating tumor cells (CTC) detection: clinical impact and future directions. Cancer Lett. 253(2), 180–204 (2007).
  • Amato RJ, Melnikova V, Zhang Y et al. Epithelial cell adhesion molecule-positive circulating tumor cells as predictive biomarker in patients with prostate cancer. Urology 81(6), 1303–1307 (2013).
  • Shamash J, Jacob J, Agrawal S et al. Whole blood stem cell reinfusion and escalated dose melphalan in castration-resistant prostate cancer: a phase 1 study. Clin. Cancer Res. 18(8), 2352–2359 (2012).
  • Li C, Heidt DG, Dalerba P et al. Identification of pancreatic cancer stem cells. Cancer Res. 67(3), 1030–1037 (2007).
  • Hermann PC, Huber SL, Herrler T et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 1(3), 313–323 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.